All Stories

  1. Treatable traits in the NOVELTY study

    Article • Respirology, July 2022, Wiley

    Alvar Agustí, Dr Dimitar Sajkov

  2. Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial

    Article • European Respiratory Journal, February 2022, European Respiratory Society (ERS)

    Alvar Agustí

  3. Treatable traits in the NOVELTY study: prevalence, patterns and relationship with physician-assessed severity

    Article • September 2021, European Respiratory Society (ERS)

    Alvar Agustí

  4. Transitioning from infancy to adulthood: a black box full of opportunities

    Article • European Respiratory Journal, March 2021, European Respiratory Society (ERS)

    Alvar Agustí

  5. Characteristics of patients with physician-assigned COPD without airflow obstruction in NOVELTY

    Article • September 2020, European Respiratory Society (ERS)

    Alvar Agustí

  6. Withdrawal of inhaled corticosteroids in COPD

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Alvar Agustí

  7. Time for a change: anticipating the diagnosis and treatment of COPD

    Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

    Alvar Agustí

  8. An imported case of e-cigarette or vaping associated lung injury in Barcelona

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Alvar Agustí

  9. Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART

    Article • PLoS ONE, October 2019, PLOS

    Alvar Agustí

  10. Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    Alvar Agustí

  11. Inhaled corticosteroids in COPD: friend or foe?

    Article • European Respiratory Journal, September 2018, European Respiratory Society (ERS)

    Alvar Agustí

  12. The disease model: implications for clinical practice

    Article • European Respiratory Journal, April 2018, European Respiratory Society (ERS)

    Alvar Agustí

  13. From systems biology to P4 medicine: applications in respiratory medicine

    Article • European Respiratory Review, February 2018, European Respiratory Society (ERS)

    Alvar Agustí

  14. COPD: time to improve its taxonomy?

    Article • ERJ Open Research, January 2018, European Respiratory Society (ERS)

    Alvar Agustí

  15. Natural history of COPD: gaps and opportunities

    Article • ERJ Open Research, October 2017, European Respiratory Society (ERS)

    Alvar Agustí

  16. Precision medicine in airway diseases: moving to clinical practice

    Article • European Respiratory Journal, October 2017, European Respiratory Society (ERS)

    Alvar Agustí

  17. Multi-level differential network analysis of COPD exacerbations

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Alvar Agustí

  18. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 20th Anniversary: a brief history of time

    Article • European Respiratory Journal, July 2017, European Respiratory Society (ERS)

    Alvar Agustí

  19. Perception of symptoms and quality of life – comparison of patients’ and physicians’ views in the COPD MIRROR study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, July 2017, Dove Medical Press

    Professor francesco blasi, Valeria Pegoraro, Claus Vogelmeier, Mina Gaga, Alvar Agustí

  20. Predicting the future from the past: volatile markers for respiratory infections

    Article • European Respiratory Journal, May 2017, European Respiratory Society (ERS)

    Alvar Agustí

  21. Predicting the future from the past

    Article • European Respiratory Journal, January 2017, European Respiratory Society (ERS)

    Alvar Agustí